Literature DB >> 21784396

Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling.

Christopher S Ennen1, Thierry A G M Huisman, William J Savage, Frances J Northington, Jacky M Jennings, Allen D Everett, Ernest M Graham.   

Abstract

OBJECTIVE: Glial fibrillary acidic protein (GFAP) is specific to astrocytes in the central nervous system. We hypothesized that serum GFAP would be increased in neonates with hypoxic-ischemic encephalopathy (HIE) treated with whole-body cooling. STUDY
DESIGN: We measured GFAP at birth and daily for up to 7 days for neonates in the intensive care unit. We compared neonates with HIE treated with whole-body cooling to gestational age-matched controls without neurological injury and neonates with HIE by brain abnormalities on magnetic resonance imaging (MRI).
RESULTS: Neonates with HIE had increased GFAP levels compared with controls. Neonates with HIE and abnormal brain imaging had elevated GFAP levels compared with neonates with HIE and normal imaging.
CONCLUSION: Serum GFAP levels during the first week of life were increased in neonates with HIE and were predictive of brain injury on MRI. Biomarkers such as GFAP could help triage neonates with HIE to treatment, measure treatment efficacy, and provide prognostic information. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784396      PMCID: PMC4011017          DOI: 10.1016/j.ajog.2011.06.025

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  31 in total

Review 1.  Cooling the newborn after asphyxia - physiological and experimental background and its clinical use.

Authors:  M Thoresen
Journal:  Semin Neonatol       Date:  2000-02

2.  Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum.

Authors:  Douglas D Fraser; Taylor E Close; Keeley L Rose; Roxanne Ward; Martin Mehl; Catherine Farrell; Jacques Lacroix; David Creery; Murray Kesselman; Danica Stanimirovic; James S Hutchison
Journal:  Pediatr Crit Care Med       Date:  2011-05       Impact factor: 3.624

3.  Origin and timing of brain lesions in term infants with neonatal encephalopathy.

Authors:  Frances Cowan; Mary Rutherford; Floris Groenendaal; Paula Eken; Eugenio Mercuri; Graeme M Bydder; Linda C Meiners; Lilly M S Dubowitz; Linda S de Vries
Journal:  Lancet       Date:  2003-03-01       Impact factor: 79.321

4.  GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.

Authors:  Linda E Pelinka; Alfred Kroepfl; Martin Leixnering; Walter Buchinger; Andreas Raabe; Heinz Redl
Journal:  J Neurotrauma       Date:  2004-11       Impact factor: 5.269

5.  Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy.

Authors:  Seetha Shankaran; Abbot R Laptook; Richard A Ehrenkranz; Jon E Tyson; Scott A McDonald; Edward F Donovan; Avroy A Fanaroff; W Kenneth Poole; Linda L Wright; Rosemary D Higgins; Neil N Finer; Waldemar A Carlo; Shahnaz Duara; William Oh; C Michael Cotten; David K Stevenson; Barbara J Stoll; James A Lemons; Ronnie Guillet; Alan H Jobe
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

6.  Neurological and perceptual-motor outcome at 5 - 6 years of age in children with neonatal encephalopathy: relationship with neonatal brain MRI.

Authors:  A Barnett; E Mercuri; M Rutherford; L Haataja; M F Frisone; S Henderson; F Cowan; L Dubowitz
Journal:  Neuropediatrics       Date:  2002-10       Impact factor: 1.947

Review 7.  A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy.

Authors:  Ernest M Graham; Kristy A Ruis; Adam L Hartman; Frances J Northington; Harold E Fox
Journal:  Am J Obstet Gynecol       Date:  2008-12       Impact factor: 8.661

8.  Glial fibrillary acidic protein is highly correlated with brain injury.

Authors:  Kimberly M Lumpkins; Grant V Bochicchio; Kaspar Keledjian; J Marc Simard; Maureen McCunn; Thomas Scalea
Journal:  J Trauma       Date:  2008-10

Review 9.  Cell therapy for neonatal hypoxic-ischemic encephalopathy.

Authors:  Pedro M Pimentel-Coelho; Rosalia Mendez-Otero
Journal:  Stem Cells Dev       Date:  2010-03       Impact factor: 3.272

10.  A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.

Authors:  Dwight J Rouse; Deborah G Hirtz; Elizabeth Thom; Michael W Varner; Catherine Y Spong; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; James M Alexander; Margaret Harper; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Menachem Miodovnik; Atef Moawad; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Oded Langer; Steve N Caritis; James M Roberts
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

View more
  46 in total

Review 1.  Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease.

Authors:  Eboni I Lance; James F Casella; Allen D Everett; Emily Barron-Casella
Journal:  Proteomics Clin Appl       Date:  2014-11-06       Impact factor: 3.494

2.  Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy.

Authors:  Lina F Chalak; Pablo J Sánchez; Beverley Adams-Huet; Abbot R Laptook; Roy J Heyne; Charles R Rosenfeld
Journal:  J Pediatr       Date:  2013-12-12       Impact factor: 4.406

3.  Circulating blood cellular glucose transporters - Surrogate biomarkers for neonatal hypoxic-ischemic encephalopathy assessed by novel scoring systems.

Authors:  Liesbeth V Maggiotto; Monica Sondhi; Bo-Chul Shin; Meena Garg; Sherin U Devaskar
Journal:  Mol Genet Metab       Date:  2019-05-29       Impact factor: 4.797

4.  The search continues: neuroprotection for all neonates with hypoxic-ischemic encephalopathy.

Authors:  Jennifer K Lee; An N Massaro; Frances J Northington
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

5.  Impaired cerebral autoregulation and elevation in plasma glial fibrillary acidic protein level during cardiopulmonary bypass surgery for CHD.

Authors:  Ronald B Easley; Bradley S Marino; Jacky Jennings; Amy E Cassedy; Kathleen K Kibler; Ken M Brady; Dean B Andropoulos; Marissa Brunetti; Charles W Hogue; Eugenie S Heitmiller; Jennifer K Lee; James Spaeth; Allen D Everett
Journal:  Cardiol Young       Date:  2017-08-24       Impact factor: 1.093

6.  Glial fibrillary acidic protein as a biomarker for brain injury in neonatal CHD.

Authors:  Stephanie L McKenney; Fahad F Mansouri; Allen D Everett; Ernest M Graham; Irina Burd; Priya Sekar
Journal:  Cardiol Young       Date:  2016-01-20       Impact factor: 1.093

7.  Identification and characterization of citrulline-modified brain proteins by combining HCD and CID fragmentation.

Authors:  Zhicheng Jin; Zongming Fu; Jun Yang; Juan Troncosco; Allen D Everett; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2013-08-07       Impact factor: 3.984

8.  Exploratory study of serum ubiquitin carboxyl-terminal esterase L1 and glial fibrillary acidic protein for outcome prognostication after pediatric cardiac arrest.

Authors:  Ericka L Fink; Rachel P Berger; Robert S B Clark; R Scott Watson; Derek C Angus; Ashok Panigrahy; Rudolph Richichi; Clifton W Callaway; Michael J Bell; Stefania Mondello; Ronald L Hayes; Patrick M Kochanek
Journal:  Resuscitation       Date:  2016-02-06       Impact factor: 5.262

9.  Biomarkers S100B and neuron-specific enolase predict outcome in hypothermia-treated encephalopathic newborns*.

Authors:  An N Massaro; Taeun Chang; Stephen Baumgart; Robert McCarter; Karin B Nelson; Penny Glass
Journal:  Pediatr Crit Care Med       Date:  2014-09       Impact factor: 3.624

Review 10.  Inflammatory Biomarkers of Birth Asphyxia.

Authors:  Lina F Chalak
Journal:  Clin Perinatol       Date:  2016-09       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.